Skip to main content
Lipella Pharmaceuticals Inc. (LIPO)
NASDAQ: LIPO · IEX Real-Time Price · USD
0.440
-0.016 (-3.51%)
At close: Jul 2, 2024, 3:59 PM
0.454
+0.014 (3.16%)
After-hours: Jul 2, 2024, 4:00 PM EDT

Lipella Pharmaceuticals Stock Forecast

Stock Price Forecast

The 1 analyst with a 12-month price forecast for LIPO stock has a target of 2.00, which predicts an increase of 354.44% from the current stock price of 0.44.

Analyst Consensus: Strong Buy
Target Low Average Median High
Price $2.00 $2.00 $2.00 $2.00
Change +354.44% +354.44% +354.44% +354.44%
* Price targets were last updated on Apr 9, 2024.

Analyst Ratings

According to 1 stock analyst, the rating for LIPO is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Jun '24Jul '24
Strong Buy 11
Buy 00
Hold 00
Sell 00
Strong Sell 00
Total 11

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Jason McCarthy
Maxim Group
 Maxim Group
Strong Buy
Initiates
$2
 Strong Buy Initiates $2 +354.44% Apr 9, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
148.92K
from 449.62K
Decreased by -66.88%
Revenue Next Year
n/a
from 148.92K
EPS This Year
-0.28
from -0.77
EPS Next Year
-0.23
from -0.28
Year 2020202120222023202420252026
Revenue
961.68K259.35K184.16K449.62K148.92K--
Revenue Growth
--73.03%-28.99%144.15%-66.88%--
EPS
-0.01-0.55-0.64-0.77-0.28-0.23-0.26
EPS Growth
-------
Forward PE
-------
No. Analysts ----333
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 202420252026
High 153,300 n/a n/a
Avg 148,920 n/a n/a
Low 143,080 n/a n/a

Revenue Growth

Revenue Growth 202420252026
High
-65.9%
- -
Avg
-66.9%
- -
Low
-68.2%
- -

EPS Forecast

EPS 202420252026
High -0.28 -0.24 -0.26
Avg -0.28 -0.23 -0.26
Low -0.26 -0.23 -0.25

EPS Growth

EPS Growth 202420252026
High - - -
Avg - - -
Low - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.